stimuli in the field defect. But when the lateral geniculate nucleus was reversibly inactivated by the GABA agonist THIP -the effective region of which was visualised by concurrent structural magnetic imaging and by also injecting the magnetic resonance contrast-agent gadolinium -both the extrastriate activity and the behavioural discrimination were abolished.
As the GABA agonist does not affect the retinal axons passing beneath the
LGN en route to the superior colliculus, the role of the latter and other mid-brain centres in blindsight has to be re-evaluated. Further steps are likely to include whether the pathway from eye to superior colliculus is indeed important but that the output from superior colliculus is routed via the interlaminar layers of the LGN. It will also be important to record from the amygdala, often implicated in affective blindsight [15, 16] such as responses to emotional visual stimuli, in order to determine whether the amygdala has a privileged visual input that is independent of the LGN and might involve the collicular projections to the pulvinar nucleus and/ or the medial dorsal thalamus. Lastly, as icing on the cake, it should be possible to demonstrate behaviourally that such monkeys are displaying blindsight when they respond. It seems that the resolution of a longstanding problem is at last in sight. [2, 3] . These effects require both AGO1 and AGO2 and the siRNA guide strand is supposed to base pair with RNA encoded by the promoter resulting from genome-wide pervasive transcription. Inspired by mammalian TGS, we recently showed that if, instead of targeting promoters, siRNAs are directed to sequences in the body of a gene, mapping at the intron downstream of an alternative exon, the siRNA leading strand base-pairs with the nascent pre-mRNA and subsequently generates a closed chromatin structure that, by creating a roadblock to RNA polymerase II (Pol II) elongation, affects alternative splicing [4] . The effect needs both AGO1 and AGO2 and is abolished or reduced by factors that favor an open chromatin structure or increase transcriptional elongation. The mechanism, named TGS-regulated alternative splicing (TGS-AS), involves the formation of facultative heterochromatin histone marks (H3K9me2 and H3K27me3) at the target site and downstream, plus the recruitment of the heterochromatin protein HP1. These chromatin changes affect the kinetic coupling mechanism between alternative splicing and transcription according to which the rate of transcription elongation determines the outcome of two competing splicing reactions that occur co-transcriptionally. Rapid, highly processive transcription favors exon skipping, whereas slower, less processive transcription favors the inclusion process [5, 6] .
A recent report published in Nature by the Kennedy group [7] elucidates 
Figure 1. Transcriptional gene silencing (TGS) and TGS-regulated alternative splicing (TGS-AS).
(A) A model for TGS in C. elegans. The argonaute protein NRDE-3 transports siRNAs from the cytoplasm to the nucleus. Another argonaute protein, NEDE-2, is necessary for the base pairing between the siRNA guide strand and nascent RNA. This interaction promotes trimethylation of H3K9 (nucleosomes in brown) and subsequent stalling of RNA polymerase II (Pol II). The graph at the bottom illustrates the dramatic decrease in pre-mRNA abundance downstream of the siRNA target site upon siRNA action. This decrease is observed in wildtype (solid blue line) but not in nrde-2(-) worms (solid red line). Chromatin immunoprecipitation analysis reveals a peak for Pol II at the siRNA target region in wild-type (broken blue line) but not in nrde-2(-) worms (broken red line). Based on Guang et al. [7] . (B) A model for TGS-AS in human cells. Transfection with siRNAs targeting the intron mapping downstream of the alternative exon (dark yellow) promotes dimethylation and trimethylation of H3K9 and H3K27, respectively (nucleosomes in brown). Silencing is triggered by a silencing complex involving an siRNA guide strand and AGO1. HP1a is recruited and the resulting condensed chromatin structure generates roadblocks to Pol II elongation, causing higher inclusion of the alternative exon according to the kinetic coupling model. Based on Alló et al. [4] . the precise roles of two C. elegans Argonaute factors involved in TGS and, more importantly, confirms the importance of TGS in the control of transcriptional elongation. The C. elegans Argonaute protein NRDE-3 was known to transport siRNAs from the cytoplasm to the nucleus and therefore to be necessary for TGS. Guang et al. [7] identified a new protein, NRDE-2, which is also necessary for nuclear RNA interference (RNAi) (TGS). In fact, nrde-2 mutant worms fail to both silence specific targets of exogenous siRNAs and produce the dramatic multivulva phenotype induced by RNAi targeting of the endogenous nuclear lin-15b RNA. NRDE-2 is a 130 kDa nuclear protein containing a conserved domain of unknown function (DUF) and two domains usually found in RNA processing factors: a serine/arginine-rich domain typical of SR proteins and a half-atetratricopeptide (HAT)-like domain. Most interesting, NRDE-2 has single orthologues in plants, S. pombe, Drosophila and mammals. The authors demonstrate that NRDE-2 functions downstream of NRDE-3 as NRDE-2 mutations do not affect siRNA transport to the nucleus, but this transport per se is not sufficient to trigger TGS. Within the nucleus, siRNA-NRDE-3-NRDE-2 complexes are recruited to nascent pre-mRNAs containing target sequences through base pairing with the siRNA guide strand. Several experiments suggest that NRDE-2 dependent TGS inhibits Pol II during elongation. Efficient silencing in C. elegans is dependent on the Rpb-7 subunit of Pol II, previously found to be necessary for siRNA-mediated heterochromatin formation in S. pombe [8] . As in TGS-AS, siRNAs complexed with NRDE-3 and NRDE-2 interact with unspliced mRNAs, thought to be processed co-transcriptionally. Furthermore, in an NRDE-2-dependent manner, siRNAs elicit H3K9 trimethylation at the target genomic sites and silencing of transcription, but only downstream of the siRNA target site, which was detected both by steady-state pre-mRNA quantification and run-on analysis. Finally, and most conclusively, chromatin immunoprecipitation experiments using anti-Pol II antibodies demonstrate that Pol II peaks at the siRNA target sites in nrde-2(+) but not in nrde-2(-) cells. The Pol II peak detected in C. elegans parallels the transcriptional roadblock postulated to explain the reduction in elongation observed in TGS-AS in human cells [4] . Figure 1 compares the mechanisms for TGS in C. elegans and TGS-AS in human cells.
These findings highlight the role of RNAi-mediated chromatin modification in the expression of genes not embedded in constitutive heterochromatin regions like pericentromeric chromatin or highly repetitive sequences. In euchromatic genes, siRNAs can create local, intragenic and restricted heterochromatin marks that would affect Pol II elongation. When transcription is inhibited at the initiation level, only the quantity of the resulting mRNA can be affected. Instead, inhibition of elongation not only affects the quantity but also the quality of the produced mRNA by influencing pre-mRNA processing events such as splicing.
Many questions remain unanswered. What is the function of the NERD-2 orthologue of mammalian cells? Is it necessary for mammalian TGS? Both the NERD-2-dependent TGS in C. elegans and mammalian TGS-AS were demonstrated for exogenous siRNAs. Are there endogenous small RNAs playing similar roles? Potential candidates are Piwi RNAs [9] and endogenous siRNAs (esiRNAs) [10] , which have been shown to regulate gene expression in mammalian cells through histone modifications and DNA methylation; miRNAs, recently shown to trigger TGS in the moss Physcomitrella patens [11] and mammalian cells [12] , and double-stranded RNAs resulting from bidirectional and overlapping transcription, and which trigger epigenetic silencing, are also good candidates [13] . Finally, the possibility that intragenic TGS may control alternative splicing in mammalian cells depending on the siRNA target site raises the converse question of whether NRDE-2-dependent TGS controls essential pre-mRNA processing mechanisms in C. elegans such as trans-splicing.
The results reported by Guang et al. [7] contribute to our evolving view of gene expression, from PTGS to TGS, from chromatin/transcription at promoters to the interior of genes, from initiation to elongation and from putative uniform distributions of Pol II molecules along a gene to a landscape of intragenic Pol II peaks representing barriers to elongation. Most importantly, a detailed knowledge of the mechanisms controlling intragenic chromatin modifications will have a significant impact on the emerging field concerned with the relationship between chromatin and splicing [14, 15] .
